BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6171018)

  • 1. Monosodium glutamate exposure in the neonate alters hypothalamic and pituitary neuropeptide levels in the adult.
    Hong JS; Lowe C; Squibb RE; Lamartiniere CA
    Regul Pept; 1981 Nov; 2(6):347-52. PubMed ID: 6171018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of neonatal treatment with monosodium glutamate on vasopressin release during foot shock stress in the rat.
    Knepel W; Nutto D; Hertting G
    Life Sci; 1983 Oct; 33(17):1703-9. PubMed ID: 6314081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of neonatal treatment with monosodium glutamate on the secretion of alpha-MSH, beta-endorphin and ACTH in the rat.
    Conte-Devolx B; Giraud P; Castanas E; Boudouresque F; Orlando M; Gillioz P; Oliver C
    Neuroendocrinology; 1981; 33(4):207-11. PubMed ID: 6270587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of neonatal administration of monosodium glutamate on four neuropeptide concentrations in the rat brain].
    Hashigami Y
    Nihon Naibunpi Gakkai Zasshi; 1989 Feb; 65(2):79-90. PubMed ID: 2568279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distribution of enkephalin in the mediobasal hypothalamus of the mouse brain: effects of neonatal administration of MSG.
    Romagnano MA; Chafel TL; Pilcher WH; Joseph SA
    Brain Res; 1982 Mar; 236(2):497-504. PubMed ID: 7039767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monosodium glutamate increases NGF and NPY concentrations in rat hypothalamus and pituitary.
    Tirassa P; Lundeberg T; Stenfors C; Bracci-Laudiero L; Theodorsson E; Aloe L
    Neuroreport; 1995 Dec; 6(18):2450-2. PubMed ID: 8741739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential alterations in opioid analgesia following neonatal monosodium glutamate treatment.
    Bodnar RJ; Portzline T; Nilaver G
    Brain Res Bull; 1985 Sep; 15(3):299-305. PubMed ID: 2932202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related and diurnal changes in Met5-Enk-Arg6-Phe7 and Met5-enkephalin contents of pituitary and rat brain structures.
    Tang F; Tang J; Chou J; Costa E
    Life Sci; 1984 Aug; 35(9):1005-14. PubMed ID: 6088930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of hypothalamic endorphins after repeated injections of anorectics which release serotonin.
    Harsing LG; Yang HY; Costa E
    J Pharmacol Exp Ther; 1982 Dec; 223(3):689-94. PubMed ID: 6292396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased responsiveness of the hypothalamic-pituitary axis after neurotoxin-induced hypothalamic denervation.
    Spinedi E; Johnston C; Negro-Vilar A
    Endocrinology; 1984 Jul; 115(1):267-72. PubMed ID: 6145582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monosodium glutamate (MSG) alters protein, vasopressin, and oxytocin in microdissected hypothalamic areas in newborn and adult rats.
    Schubert F; George JM; Rao MB
    Life Sci; 1980 Feb; 26(8):651-6. PubMed ID: 7382742
    [No Abstract]   [Full Text] [Related]  

  • 12. On the origin of Leu-enkephalin and Met-enkephalin in the rat neurohypophysis.
    Zamir N
    Endocrinology; 1985 Oct; 117(4):1687-92. PubMed ID: 2863131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlordecone (Kepone) exposure in the neonate selectively alters brain and pituitary endorphin levels in prepuberal and adult rats.
    Hong JS; Ali SF
    Neurotoxicology; 1982 Oct; 3(2):111-8. PubMed ID: 6186955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid-mediated cardiovascular effects of clonidine in spontaneously hypertensive rats: elimination by neonatal treatment with monosodium glutamate.
    Mosqueda-Garcia R; Eskay R; Zamir N; Palkovits M; Kunos G
    Endocrinology; 1986 May; 118(5):1814-22. PubMed ID: 2938932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MSG effects on beta-endorphin and alpha-MSH in the hypothalamus and caudal medulla.
    Alessi NE; Quinlan P; Khachaturian H
    Peptides; 1988; 9(4):689-95. PubMed ID: 2852357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monosodium glutamate lesions in rat hypothalamus studied by immunohistochemistry for gonadotropin releasing hormone, neurotensin, tyrosine hydroxylase, and glutamic acid decarboxylase and by autoradiography for [3H] estradiol.
    Jennes L; Stumpf WE; Bissette G; Nemeroff CB
    Brain Res; 1984 Aug; 308(2):245-53. PubMed ID: 6148123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions.
    Meister B; Ceccatelli S; Hökfelt T; Andén NE; Andén M; Theodorsson E
    Exp Brain Res; 1989; 76(2):343-68. PubMed ID: 2569986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal monosodium glutamate. Effects upon analgesic responsivity and immunocytochemical ACTH/beta-lipotropin.
    Bodnar RJ; Abrams GM; Zimmerman EA; Krieger DT; Nicholson G; Kizer JS
    Neuroendocrinology; 1980 May; 30(5):280-4. PubMed ID: 6247667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic effects of chronic nicotine treatment on hypothalamic immunoreactive beta-endorphin in the mouse.
    Rosecrans JA; Hendry JS; Hong JS
    Pharmacol Biochem Behav; 1985 Jul; 23(1):141-3. PubMed ID: 2412241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neonatal administration of monosodium glutamate and castration on neurokinin A levels in the hypothalamus and anterior pituitary of rats.
    Villanúa MA; Debeljuk L; Ghosh PK; Bartke A
    Peptides; 1992; 13(2):377-81. PubMed ID: 1329045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.